Journal Home > Online First
Nano Biomedicine and Engineering https://doi.org/10.26599/NBE.2024.9290078
Review | Open Access | Online first | Published: 11 May 2024

A Comprehensive Review on Metal–Organic Frameworks for Stimuli-responsive-based Drug Delivery: Recent Advances and Future Trends

Show Author's Information Jitendra H. Patil1,3( ),  Jayvadan K Patel2,3,  Ujashkumar A. Shah3,  Pravin O. Patil1,  Arjun S. Chaudhari2,  Hardik H. Goswami4
Department of Pharmaceutical Chemistry, H. R. Patel Institute of Pharmaceutical Education and Research, Shirpur, Dhule (MS) 425405, India
Aavis Pharmaceuticals, Hoschton, GA 30548, USA
Faculty of Pharmacy, Nootan Pharmacy College, Sankalchand Patel University, Visnagar, Gujarat, India
Biostatics and Research Decision Science Health Economics and Decision Sciences, Merck & Co., North Wale, PA, USA
Keywords:
bioimaging, stimuli-responsive, metal–organic frameworks (MOFs), anticancer
Cite this article:
Patil JH, Patel JK, Shah UA, et al. A Comprehensive Review on Metal–Organic Frameworks for Stimuli-responsive-based Drug Delivery: Recent Advances and Future Trends. Nano Biomedicine and Engineering, 2024, https://doi.org/10.26599/NBE.2024.9290078
Download citation
EndNote(RIS)
BibTeX

220

Views

38

Downloads

Citations

0

Crossref

N/A

WoS

0

Scopus

N/A

CSCD

Abstract Full text About this article

Cancer treatment has witnessed the emergence of innovative stimuli-responsive nanotherapeutics aiming to overcome limitations associated with traditional drug delivery systems. Metal–organic frameworks (MOFs), a subset of inorganic nanomaterials, are known for their porous structures and versatile applications in integrated cancer diagnosis and therapy. Their noteworthy features include customizable porosity, diverse chemical configurations, adjustable sizes and shapes, and the potential for surface functionalization. The study delved into conventional cancer therapies, provided an overview of MOFs, and discussed various MOF synthesis approaches. Furthermore, this review explored the development of stimuli-responsive MOFs to enhance targeted drug delivery and bioimaging, improving the overall efficacy of cancer treatment, and investigated the applications of stimuli-responsive multifunctional MOFs in nanostructures activated by factors influencing precise drug delivery and bioimaging in cancers. pH, light, ions, temperature, magnetic field, redox reactions, and ATP contribute to the precise control of drug delivery and bioimaging processes. Designed multifunctional MOFs exhibit characteristic changes in response to external and internal stimuli, proving advantageous for drug release and bioimaging. Surface-modified MOFs with responsive features demonstrate excellent biocompatibility with noncancerous cells, efficient drug-loading capabilities, and nanocarrier-mediated targeted drug delivery to cancerous cells. Therefore, the innovative strategy of inorganic nanoscale MOFs with responsive properties holds significant promise for targeted therapeutic drug delivery and imaging across diverse malignancies. The growing interest in stimuli-activated MOFs will open new opportunities in cancer theragnostic applications.


menu
Abstract
Full text
Outline
About this article

A Comprehensive Review on Metal–Organic Frameworks for Stimuli-responsive-based Drug Delivery: Recent Advances and Future Trends

Show Author's information Jitendra H. Patil1,3( ), Jayvadan K Patel2,3, Ujashkumar A. Shah3, Pravin O. Patil1, Arjun S. Chaudhari2, Hardik H. Goswami4
Department of Pharmaceutical Chemistry, H. R. Patel Institute of Pharmaceutical Education and Research, Shirpur, Dhule (MS) 425405, India
Aavis Pharmaceuticals, Hoschton, GA 30548, USA
Faculty of Pharmacy, Nootan Pharmacy College, Sankalchand Patel University, Visnagar, Gujarat, India
Biostatics and Research Decision Science Health Economics and Decision Sciences, Merck & Co., North Wale, PA, USA

Abstract

Cancer treatment has witnessed the emergence of innovative stimuli-responsive nanotherapeutics aiming to overcome limitations associated with traditional drug delivery systems. Metal–organic frameworks (MOFs), a subset of inorganic nanomaterials, are known for their porous structures and versatile applications in integrated cancer diagnosis and therapy. Their noteworthy features include customizable porosity, diverse chemical configurations, adjustable sizes and shapes, and the potential for surface functionalization. The study delved into conventional cancer therapies, provided an overview of MOFs, and discussed various MOF synthesis approaches. Furthermore, this review explored the development of stimuli-responsive MOFs to enhance targeted drug delivery and bioimaging, improving the overall efficacy of cancer treatment, and investigated the applications of stimuli-responsive multifunctional MOFs in nanostructures activated by factors influencing precise drug delivery and bioimaging in cancers. pH, light, ions, temperature, magnetic field, redox reactions, and ATP contribute to the precise control of drug delivery and bioimaging processes. Designed multifunctional MOFs exhibit characteristic changes in response to external and internal stimuli, proving advantageous for drug release and bioimaging. Surface-modified MOFs with responsive features demonstrate excellent biocompatibility with noncancerous cells, efficient drug-loading capabilities, and nanocarrier-mediated targeted drug delivery to cancerous cells. Therefore, the innovative strategy of inorganic nanoscale MOFs with responsive properties holds significant promise for targeted therapeutic drug delivery and imaging across diverse malignancies. The growing interest in stimuli-activated MOFs will open new opportunities in cancer theragnostic applications.

Keywords: bioimaging, stimuli-responsive, metal–organic frameworks (MOFs), anticancer

References(98)

[1]

A.L. Ho. Immunotherapy, chemotherapy, or both: Options for first-line therapy for patients with recurrent or metastatic head and neck squamous cell carcinoma. Journal of Clinical Oncology, 2023, 41(4): 736−741. https://doi.org/10.1200/jco.22.01408
DOI Google Scholar
[2]

M.M.F.A. Baig, C.F. Zhang, M.F. Akhtar, et al. Treatment of Wilms’ nephroblastoma cancer cells via EGFR targeting of dactinomycin loaded DNA-nanowires. Journal of Pharmaceutical Investigation, 2021, 51(2): 233−242. https://doi.org/10.1007/s40005-020-00509-5
DOI Google Scholar
[3]

R. Bajracharya, J.G. Song, B.R. Patil, et al. Functional ligands for improving anticancer drug therapy: Current status and applications to drug delivery systems. Drug Delivery, 2022, 29(1): 1959−1970. https://doi.org/10.1080/10717544.2022.2089296
DOI Google Scholar
[4]

M.T. Manzari, Y. Shamay, H. Kiguchi, et al. Targeted drug delivery strategies for precision medicines. Nature Reviews Materials, 2021, 6(4): 351−370. https://doi.org/10.1038/s41578-020-00269-6
DOI Google Scholar
[5]
A.A. Yetisgin, S. Cetinel, M. Zuvin, et al. Therapeutic nanoparticles and their targeted delivery applications. Molecules, 2020, 25(9): 2193.
DOI
[6]

H. Beck, M. Härter, B. Haß, et al. Small molecules and their impact in drug discovery: A perspective on the occasion of the 125th anniversary of the Bayer Chemical Research Laboratory. Drug Discovery Today, 2022, 27(6): 1560−1574. https://doi.org/10.1016/j.drudis.2022.02.015
DOI Google Scholar
[7]

M.Y. Errahmani, M. Locquet, D. Spoor, et al. Association between cardiac radiation exposure and the risk of arrhythmia in breast cancer patients treated with radiotherapy: A case–control study. Frontiers in Oncology, 2022, 12: 892882. https://doi.org/10.3389/fonc.2022.892882
DOI Google Scholar
[8]

D. Zhang, X.C. Xu, Y.A. Wei, et al. Prognostic role of DNA damage response genes mutations and their association with the sensitivity of olaparib in prostate cancer patients. Cancer Control, 2022, 29: 107327482211294. https://doi.org/10.1177/10732748221129451
DOI Google Scholar
[9]

T.L. Clarke, R. Mostoslavsky. DNA repair as a shared hallmark in cancer and ageing. Molecular Oncology, 2022, 16(18): 3352−3379. https://doi.org/10.1002/1878-0261.13285
DOI Google Scholar
[10]

N.F. Hosseini, R. Amini, M. Ramezani, et al. AS1411 aptamer-functionalized exosomes in the targeted delivery of doxorubicin in fighting colorectal cancer. Biomedicine &Pharmacotherapy, 2022, 155: 113690. https://doi.org/10.1016/j.biopha.2022.113690
DOI Google Scholar
[11]

A. Dadwal, A. Baldi, R. Kumar Narang. Nanoparticles as carriers for drug delivery in cancer. Artificial Cells,Nanomedicine,and Biotechnology, 2018, 46(sup2): 295−305. https://doi.org/10.1080/21691401.2018.1457039
DOI Google Scholar
[12]

S.H. Rim, G.P. Jr. Guy, K.R. Yabroff, et al. The impact of chronic conditions on the economic burden of cancer survivorship: A systematic review. Expert Review of Pharmacoeconomics &Outcomes Research, 2016, 16(5): 579−589. https://doi.org/10.1080/14737167.2016.1239533
DOI Google Scholar
[13]

Z. Li, S.R. Tan, S. Li, et al. Cancer drug delivery in the nano era: An overview and perspectives. Oncology Reports, 2017, 38(2): 611−624. https://doi.org/10.3892/or.2017.5718
DOI Google Scholar
[14]

W.T. Xia, Z.X. Tao, B. Zhu, et al. Targeted delivery of drugs and genes using polymer nanocarriers for cancer therapy. International Journal of Molecular Sciences, 2021, 22(17): 9118. https://doi.org/10.3390/ijms22179118
DOI Google Scholar
[15]

I.K. Herrmann, M.J.A. Wood, G. Fuhrmann. Extracellular vesicles as a next-generation drug delivery platform. Nature Nanotechnology, 2021, 16(7): 748−759. https://doi.org/10.1038/s41565-021-00931-2
DOI Google Scholar
[16]

Y.F. Jia, S.W. Chen, C.Y. Wang, et al. Hyaluronic acid-based nano drug delivery systems for breast cancer treatment: Recent advances. Frontiers in Bioengineering and Biotechnology, 2022, 10: 990145. https://doi.org/10.3389/fbioe.2022.990145
DOI Google Scholar
[17]

A.C. Anselmo, S. Mitragotri. Nanoparticles in the clinic: An update. Bioengineering &Translational Medicine, 2019, 4(3): e10143. https://doi.org/10.1002/btm2.10143
DOI Google Scholar
[18]

E. Kahraman, S. Güngör, Y. Özsoy. Potential enhancement and targeting strategies of polymeric and lipid-based nanocarriers in dermal drug delivery. Therapeutic Delivery, 2017, 8(11): 967−985. https://doi.org/10.4155/tde-2017-0075
DOI Google Scholar
[19]

F. Abedi-Gaballu, G. Dehghan, M. Ghaffari, et al. PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy. Applied Materials Today, 2018, 12: 177−190. https://doi.org/10.1016/j.apmt.2018.05.002
DOI Google Scholar
[20]

A. Sharma, D. Shambhwani, S. Pandey, et al. Advances in lung cancer treatment using nanomedicines. ACS Omega, 2023, 8(1): 10−41. https://doi.org/10.1021/acsomega.2c04078
DOI Google Scholar
[21]

V. Singh, P. Kesharwani. Dendrimer as a promising nanocarrier for the delivery of doxorubicin as an anticancer therapeutics. Journal of Biomaterials Science,Polymer Edition, 2021, 32(14): 1882−1909. https://doi.org/10.1080/09205063.2021.1938859
DOI Google Scholar
[22]

G.J. Chen, Y.Y. Wang, R.S. Xie, et al. A review on core-shell structured unimolecular nanoparticles for biomedical applications. Advanced Drug Delivery Reviews, 2018, 130: 58−72. https://doi.org/10.1016/j.addr.2018.07.008
DOI Google Scholar
[23]
G.-W. Jin, N.S. Rejinold, J.-H. Choy. Multifunctional polymeric micelles for cancer therapy. Polymers, 2022, 14(22): 4839. https://doi.org/10.3390/polym14224839
DOI
[24]

R. Rai, S. Alwani, I. Badea. Polymeric nanoparticles in gene therapy: New avenues of design and optimization for delivery applications. Polymers, 2019, 11(4): 745. https://doi.org/10.3390/polym11040745
DOI Google Scholar
[25]

B. Gorain, H. Choudhury, A.B. Nair, et al. Theranostic application of nanoemulsions in chemotherapy. Drug Discovery Today, 2020, 25(7): 1174−1188. https://doi.org/10.1016/j.drudis.2020.04.013
DOI Google Scholar
[26]

M.L. Du, Z.J. Yang, W.P. Lu, et al. Design and development of spirulina polysaccharide-loaded nanoemulsions with improved the antitumor effects of paclitaxel. Journal of Microencapsulation, 2020, 37(6): 403−412. https://doi.org/10.1080/02652048.2020.1767224
DOI Google Scholar
[27]

C. Dianzani, C. Monge, G. Miglio, et al. Nanoemulsions as delivery systems for poly-chemotherapy aiming at melanoma treatment. Cancers, 2020, 12(5): 1198. https://doi.org/10.3390/cancers12051198
DOI Google Scholar
[28]

E.B. Ribeiro, P.G.F. de Marchi, A.C. Honorio-França, et al. Interferon-gamma carrying nanoemulsion with immunomodulatory and anti-tumor activities. Journal of Biomedical Materials Research Part A, 2020, 108(2): 234−245. https://doi.org/10.1002/jbm.a.36808
DOI Google Scholar
[29]

S. Raj, S. Khurana, R. Choudhari, et al. Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy. Seminars in Cancer Biology, 2021, 69: 166−177. https://doi.org/10.1016/j.semcancer.2019.11.002
DOI Google Scholar
[30]

B. Murugan, S. Sagadevan, I. Fatimah, et al. Smart stimuli-responsive nanocarriers for the cancer therapy – nanomedicine. Nanotechnology Reviews, 2021, 10(1): 933−953. https://doi.org/10.1515/ntrev-2021-0067
DOI Google Scholar
[31]

J.H. Yao, J.X. Feng, J. Chen. External-stimuli responsive systems for cancer theranostic. Asian Journal of Pharmaceutical Sciences, 2016, 11(5): 585−595. https://doi.org/10.1016/j.ajps.2016.06.001
DOI Google Scholar
[32]

Chansi, R. Bhardwaj, K. Hadwani, et al. Role of metal–organic framework (MOF) for pesticide sensing. In: Nanoscience for Sustainable Agriculture. Cham:Springer, 2019 75−99. https://doi.org/10.1007/978-3-319-97852-9_4
DOI Google Scholar
[33]

N. Mansouriieh, M.R. Sohrabi, M. Khosravi. Optimization of profenofos organophosphorus pesticide degradation by zero-valent bimetallic nanoparticles using response surface methodology. Arabian Journal of Chemistry, 2019, 12(8): 2524−2532. https://doi.org/10.1016/j.arabjc.2015.04.009
DOI Google Scholar
[34]

H. Furukawa, K.E. Cordova, M. O’Keeffe, et al. The chemistry and applications of metal–organic frameworks. Science, 2013, 341(6149): 1230444. https://doi.org/10.1126/science.1230444
DOI Google Scholar
[35]

W.K. Li, Y.P. Shi. Recent advances and applications of carbon nanotubes based composites in magnetic solid-phase extraction. TrAC Trends in Analytical Chemistry, 2019, 118: 652−665. https://doi.org/10.1016/j.trac.2019.06.039
DOI Google Scholar
[36]

J.B. DeCoste, G.W. Peterson. Metal–organic frameworks for air purification of toxic chemicals. Chemical Reviews, 2014, 114(11): 5695−5727. https://doi.org/10.1021/cr4006473
DOI Google Scholar
[37]

F. Maya, C. Palomino Cabello, R.M. Frizzarin, et al. Magnetic solid-phase extraction using metal–organic frameworks (MOFs) and their derived carbons. TrAC Trends in Analytical Chemistry, 2017, 90: 142−152. https://doi.org/10.1016/j.trac.2017.03.004
DOI Google Scholar
[38]

A. Ebrahimi, M. Mansournia. Zeolitic imidazolate framework-7: Novel ammonia atmosphere-assisted synthesis, thermal and chemical durability, phase reversibility and potential as highly efficient nanophotocatalyst. Chemical Physics, 2018, 511: 33−45. https://doi.org/10.1016/j.chemphys.2018.06.003
DOI Google Scholar
[39]

Y.J. Sun, L.W. Zheng, Y. Yang, et al. Metal–organic framework nanocarriers for drug delivery in biomedical applications. Nano-Micro Letters, 2020, 12(1): 103. https://doi.org/10.1016/j.ijepes.2020.106218
DOI Google Scholar
[40]

C.P. Raptopoulou. Metal–organic frameworks: Synthetic methods and potential applications. Materials, 2021, 14(2): 310. https://doi.org/10.3390/ma14020310
DOI Google Scholar
[41]

M. Kalaj, S.M. Cohen. Postsynthetic modification: An enabling technology for the advancement of metal–organic frameworks. ACS Central Science, 2020, 6(7): 1046−1057. https://doi.org/10.1021/acscentsci.0c00690
DOI Google Scholar
[42]

R. Anand, F. Borghi, F. Manoli, et al. Host–guest interactions in Fe(III)-trimesate MOF nanoparticles loaded with doxorubicin. The Journal of Physical Chemistry B, 2014, 118(29): 8532−8539. https://doi.org/10.1021/jp503809w
DOI Google Scholar
[43]

C. Carrillo-Carrión. Nanoscale metal–organic frameworks as key players in the context of drug delivery: Evolution toward theranostic platforms. Analytical and Bioanalytical Chemistry, 2020, 412(1): 37−54. https://doi.org/10.1007/s00216-019-02217-y
DOI Google Scholar
[44]

Y.L. Dai, C. Xu, X.L. Sun, et al. Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment. Chemical Society Reviews, 2017, 46(12): 3830−3852. https://doi.org/10.1039/c6cs00592f
DOI Google Scholar
[45]

M.X. Wu, Y.W. Yang. Metal–Organic framework (MOF)-based drug/cargo delivery and cancer therapy. Advanced Materials, 2017, 29(23): 1606134. https://doi.org/10.1002/adma.201606134
DOI Google Scholar
[46]

Y. Yang, W.W. Zeng, P. Huang, et al. Smart materials for drug delivery and cancer therapy. VIEW, 2021, 2(2): 20200042. https://doi.org/10.1002/viw.20200042
DOI Google Scholar
[47]

M.R. Liu, H.L. Du, W.J. Zhang, et al. Internal stimuli-responsive nanocarriers for drug delivery: Design strategies and applications. Materials Science and Engineering:C, 2017, 71: 1267−1280. https://doi.org/10.1016/j.msec.2016.11.030
DOI Google Scholar
[48]

S. Mura, J. Nicolas, P. Couvreur. Stimuli-responsive nanocarriers for drug delivery. Nature Materials, 2013, 12(11): 991−1003. https://doi.org/10.1038/nmat3776
DOI Google Scholar
[49]

Y. Wang, J.H. Yan, N.C. Wen, et al. Metal–organic frameworks for stimuli-responsive drug delivery. Biomaterials, 2020, 230: 119619. https://doi.org/10.1016/j.biomaterials.2019.119619
DOI Google Scholar
[50]

M. Falsafi, A.S. Saljooghi, K. Abnous, et al. Smart metal organic frameworks: Focus on cancer treatment. Biomaterials Science, 2021, 9(5): 1503−1529. https://doi.org/10.1039/d0bm01839b
DOI Google Scholar
[51]

X.S. Guo, Y. Cheng, X.T. Zhao, et al. Advances in redox-responsive drug delivery systems of tumor microenvironment. Journal of Nanobiotechnology, 2018, 16(1): 74. https://doi.org/10.1186/s12951-018-0398-2
DOI Google Scholar
[52]

S.S.Das, P. Bharadwaj, M. Bilal, et al. Stimuli-responsive polymeric nanocarriers for drug delivery, imaging, and theragnosis. Polymers, 2020, 12(6): 1397. https://doi.org/10.3390/polym12061397
DOI Google Scholar
[53]

F. Ke, Y.P. Yuan, L.G. Qiu, et al. Facile fabrication of magnetic metal–organic framework nanocomposites for potential targeted drug delivery. Journal of Materials Chemistry, 2011, 21(11): 3843. https://doi.org/10.1039/c0jm01770a
DOI Google Scholar
[54]

S. Sharma, K. Sethi, I. Roy. Magnetic nanoscale metal–organic frameworks for magnetically aided drug delivery and photodynamic therapy. New Journal of Chemistry, 2017, 41(20): 11860−11866. https://doi.org/10.1039/c7nj02032e
DOI Google Scholar
[55]

M. Oggianu, N. Monni, V. Mameli, et al. Designing magnetic NanoMOFs for biomedicine: Current trends and applications. Magnetochemistry, 2020, 6(3): 39. https://doi.org/10.3390/magnetochemistry6030039
DOI Google Scholar
[56]

B. Nirosha Yalamandala, W.T. Shen, S.H. Min, et al. Advances in functional metal–organic frameworks based on-demand drug delivery systems for tumor therapeutics. Advanced NanoBiomed Research, 2021, 1(8): 2100014. https://doi.org/10.1002/anbr.202100014
DOI Google Scholar
[57]

J.G. Liang, B.N. Yang, , X.D. Zhou, et al. Stimuli-responsive drug delivery systems for head and neck cancer therapy. Drug Delivery, 2021, 28(1): 272−284. https://doi.org/10.1080/10717544.2021.1876182
DOI Google Scholar
[58]

A.Y. Rwei, W.P. Wang, D.S. Kohane. Photoresponsive nanoparticles for drug delivery. Nano Today, 2015, 10(4): 451−467. https://doi.org/10.1016/j.nantod.2015.06.004
DOI Google Scholar
[59]

N. Fomina, J. Sankaranarayanan, A. Almutairi. Photochemical mechanisms of light-triggered release from nanocarriers. Advanced Drug Delivery Reviews, 2012, 64(11): 1005−1020. https://doi.org/10.1016/j.addr.2012.02.006
DOI Google Scholar
[60]

C.S. Linsley, B.M. Wu. Recent advances in light-responsive on-demand drug-delivery systems. Therapeutic Delivery, 2017, 8(2): 89−107. https://doi.org/10.4155/tde-2016-0060
DOI Google Scholar
[61]

C. Yan, Y. Jin, C.X. Zhao. Environment responsive metal–organic frameworks as drug delivery system for tumor therapy. Nanoscale Research Letters, 2021, 16(1): 140. https://doi.org/10.1186/s11671-021-03597-w
DOI Google Scholar
[62]

H. Lin, S.S. Gao, C. Dai, et al. A two-dimensional biodegradable niobium carbide (MXene) for photothermal tumor eradication in NIR-I and NIR-II biowindows. Journal of the American Chemical Society, 2017, 139(45): 16235−16247. https://doi.org/10.1021/jacs.7b07818
DOI Google Scholar
[63]

W.J. Sun, S.Y. Li, G.L. Tang, et al. Recent progress of nanoscale metal–organic frameworks in cancer theranostics and the challenges of their clinical application. International Journal of Nanomedicine, 2020, 14: 10195−10207. https://doi.org/10.2147/ijn.s230524
DOI Google Scholar
[64]

A. Karmakar, A.V. Desai, S.K. Ghosh. Ionic metal–organic frameworks (iMOFs): Design principles and applications. Coordination Chemistry Reviews, 2016, 307: 313−341. https://doi.org/10.1016/j.ccr.2015.08.007
DOI Google Scholar
[65]

M.R. Cai, G.S. Chen, L.Y. Qin, et al. Metal organic frameworks as drug targeting delivery vehicles in the treatment of cancer. Pharmaceutics, 2020, 12(3): 232. https://doi.org/10.3390/pharmaceutics12030232
DOI Google Scholar
[66]

Wu Y., Zhang J., He W., et al. Nanomaterials for targeting liver disease: research progress and future perspectives. Nano Biomedicine and Engineering, 2023, 15(2): 199−224. https://doi.org/10.26599/NBE.2023.9290024
DOI Google Scholar
[67]

Z. Cheng, M.Y. Li, R. Dey, et al. Nanomaterials for cancer therapy: Current progress and perspectives. Journal of Hematology &Oncology, 2021, 14(1): 85. https://doi.org/10.1186/s13045-021-01096-0
DOI Google Scholar
[68]

Zhou W., Zhang J., Wang X., et al. Radiolabeled tracing techniques illuminating blood pharmacokinetics in nanomedicine. Nano Biomedicine and Engineering, 2024, 16(1): 48−63. https://doi.org/10.26599/NBE.2024.9290048
DOI Google Scholar
[69]

Y.Q. Zhang, J. Fang, S.Y. Ye, et al. A hydrogen sulphide-responsive and depleting nanoplatform for cancer photodynamic therapy. Nature Communications, 2022, 13: 1685. https://doi.org/10.1038/s41467-022-29284-7
DOI Google Scholar
[70]

Q.Q. Sun, H.T. Bi, Z. Wang, et al. Hyaluronic acid-targeted and pH-responsive drug delivery system based on metal–organic frameworks for efficient antitumor therapy. Biomaterials, 2019, 223: 119473. https://doi.org/10.1016/j.biomaterials.2019.119473
DOI Google Scholar
[71]

R. Abazari, F. Ataei, A. Morsali, et al. A luminescent amine-functionalized metal–organic framework conjugated with folic acid as a targeted biocompatible pH-responsive nanocarrier for apoptosis induction in breast cancer cells. ACS Applied Materials &Interfaces, 2019, 11(49): 45442−45454. https://doi.org/10.1021/acsami.9b16473
DOI Google Scholar
[72]

W.C. Liu, Y.Y. Zhong, X.X. Wang, et al. A porous Cu(II)-based metal–organic framework carrier for pH-controlled anticancer drug delivery. Inorganic Chemistry Communications, 2020, 111: 107675. https://doi.org/10.1016/j.inoche.2019.107675
DOI Google Scholar
[73]

B.H. Song, X. Ding, Z.F. Zhang, et al. Efficient drug delivery of 5-fluorouracil by a biocompatible Zn-metal–organic framework nanostructure and anti-liver cancer activity study. Journal of the Iranian Chemical Society, 2019, 16(2): 333−340. https://doi.org/10.1007/s13738-018-1520-y
DOI Google Scholar
[74]

F.-M. Zhang, H. Dong, X. Zhang, et al. Postsynthetic modification of ZIF-90 for potential targeted codelivery of two anticancer drugs. ACS Applied Materials &Interfaces, 2017, 9(32): 27332−27337. https://doi.org/10.1021/acsami.7b08451
DOI Google Scholar
[75]

A. Cabrera-García, E. Checa-Chavarria, E. Rivero-Buceta, et al. Amino modified metal–organic frameworks as pH-responsive nanoplatforms for safe delivery of camptothecin. Journal of Colloid and Interface Science, 2019, 541: 163−174. https://doi.org/10.1016/j.jcis.2019.01.042
DOI Google Scholar
[76]

X.M. Jia, Z.Y. Yang, Y.J. Wang, et al. Hollow mesoporous silica@metal–organic framework and applications for pH-responsive drug delivery. ChemMedChem, 2018, 13(5): 400−405. https://doi.org/10.1002/cmdc.201800019
DOI Google Scholar
[77]

H. Ren, L.Y. Zhang, J.P. An, et al. Polyacrylic acid@zeolitic imidazolate framework-8 nanoparticles with ultrahigh drug loading capability for pH-sensitive drug release. Chem Commun, 2014, 50(8): 1000−1002. https://doi.org/10.1039/c3cc47666a
DOI Google Scholar
[78]

T. Kundu, S. Mitra, P. Patra, et al. Mechanical downsizing of a gadolinium(III)-based metal–organic framework for anticancer drug delivery. Chemistry – A European Journal, 2014, 20(33): 10514−10518. https://doi.org/10.1002/chem.201402244
DOI Google Scholar
[79]

F. Duan, X.C. Feng, X.J. Yang, et al. A simple and powerful co-delivery system based on pH-responsive metal–organic frameworks for enhanced cancer immunotherapy. Biomaterials, 2017, 122: 23−33. https://doi.org/10.1016/j.biomaterials.2017.01.017
DOI Google Scholar
[80]

A.Q. Ma, R. Zhang. Facile synthesis of redox-responsive paclitaxel drug release platform using metal–organic frameworks (ZIF-8) for gastric cancer treatment. Materials Research Express, 2020, 7(9): 095402. https://doi.org/10.1088/2053-1591/abb2ce
DOI Google Scholar
[81]

C. Liu, X.Y. Xu, J.N. Zhou, et al. Redox-responsive tumor targeted dual-drug loaded biocompatible metal–organic frameworks for enhancing anticancer cytotoxicity. BMC Materials, 2020, 2: 7. https://doi.org/10.1186/s42833-020-00013-y
DOI Google Scholar
[82]

B.Q. Lei, M.F. Wang, Z.L. Jiang, et al. Constructing redox-responsive metal–organic framework nanocarriers for anticancer drug delivery. ACS Applied Materials &Interfaces, 2018, 10(19): 16698−16706. https://doi.org/10.1021/acsami.7b19693
DOI Google Scholar
[83]

K.D. Lu, C.B. He, W.B. Lin. Nanoscale metal–organic framework for highly effective photodynamic therapy of resistant head and neck cancer. Journal of the American Chemical Society, 2014, 136(48): 16712−16715. https://doi.org/10.1021/ja508679h
DOI Google Scholar
[84]

J.J. Chen, Y.F. Zhu, S. Kaskel. Porphyrin-based metal–organic frameworks for biomedical applications. Angewandte Chemie International Edition, 2021, 60(10): 5010−5035. https://doi.org/10.1002/anie.201909880
DOI Google Scholar
[85]

Y.C. Zhang, Q.L. Wang, G. Chen, et al. DNA-functionalized metal–organic framework: Cell imaging, targeting drug delivery and photodynamic therapy. Inorganic Chemistry, 2019, 58(10): 6593−6596. https://doi.org/10.1021/acs.inorgchem.9b00734
DOI Google Scholar
[86]

D.M. Liu, C.B. He, C. Poon, et al. Theranostic nanoscale coordination polymers for magnetic resonance imaging and bisphosphonate delivery. Journal of Materials Chemistry B, 2014, 2(46): 8249−8255. https://doi.org/10.1039/c4tb00751d
DOI Google Scholar
[87]

S. Li, K. Bi, L. Xiao, et al. Facile preparation of magnetic metal organic frameworks core–shell nanoparticles for stimuli-responsive drug carrier. Nanotechnology, 2017, 28(49): 495601. https://doi.org/10.1088/1361-6528/aa91c4
DOI Google Scholar
[88]

A.K. Ebrahimi, M. Barani, I. Sheikhshoaie. Fabrication of a new superparamagnetic metal–organic framework with core-shell nanocomposite structures: Characterization, biocompatibility, and drug release study. Materials Science &Engineering C,Materials for Biological Applications, 2018, 92: 349−355. https://doi.org/10.1016/j.msec.2018.07.010
DOI Google Scholar
[89]

W.H. Chen, X. Yu, A. Cecconello, et al. Stimuli-responsive nucleic acid-functionalized metal–organic framework nanoparticles using pH- and metal-ion-dependent DNAzymes as locks. Chemical Science, 2017, 8(8): 5769−5780. https://doi.org/10.1039/c7sc01765k
DOI Google Scholar
[90]

W.X. Lin, Q. Hu, J.C. Yu, et al. Low cytotoxic metal–organic frameworks as temperature-responsive drug carriers. ChemPlusChem, 2016, 81(8): 668. https://doi.org/10.1002/cplu.201600327
DOI Google Scholar
[91]

J.Y.R. Silva, Y.G. Proenza, L.L. da Luz, et al. A thermo-responsive adsorbent-heater-thermometer nanomaterial for controlled drug release: (ZIF-8, EuxTby)@AuNP core-shell. Materials Science &Engineering C,Materials for Biological Applications, 2019, 102: 578−588.
DOI Google Scholar
[92]

X T Yang , Q Tang, Y Jiang, et al. Nanoscale ATP-Responsive Zeolitic Imidazole Framework-90 as a General Platform for Cytosolic Protein Delivery and Genome Editing. J. Am. Chem. Soc., 2019, 141(9): 3782−3786. https://doi.org/10.1021/jacs.8b11996
DOI Google Scholar
[93]

W. Pan, B.J. Cui, K.Y. Wang, et al. ATP-triggered mitochondrial cascade reactions for cancer therapy with nanoscale zeolitic imidazole framework-90. Theranostics, 2021, 11(16): 7869−7878. https://doi.org/10.7150/thno.59593
DOI Google Scholar
[94]

X.X. Chen, M.J. Hou, G.J. Mao, et al. ATP-responsive near-infrared fluorescence MOF nanoprobe for the controlled release of anticancer drug. Microchimica Acta, 2021, 188(9): 287. https://doi.org/10.1007/s00604-021-04953-4
DOI Google Scholar
[95]

L. Zhang, S.S. Wan, C.X. Li, et al. An adenosine triphosphate-responsive autocatalytic Fenton nanoparticle for tumor ablation with self-supplied H2O2 and acceleration of Fe(III)/Fe(II) conversion. Nano Letters, 2018, 18(12): 7609−7618. https://doi.org/10.1021/acs.nanolett.8b03178
DOI Google Scholar
[96]

S.S. Wan, M.D. Liu, Q. Cheng, et al. A mitochondria-driven metabolic sensing nanosystem for oxygen availability and energy blockade of cancer. Advanced Therapeutics, 2020, 3(6): 2000019. https://doi.org/10.1002/adtp.202000019
DOI Google Scholar
[97]

Y.T. Li, J.L. Zhou, L. Wang, et al. Endogenous hydrogen sulfide-triggered MOF-based nanoenzyme for synergic cancer therapy. ACS Applied Materials &Interfaces, 2020, 12(27): 30213−30220. https://doi.org/10.1021/acsami.0c08659
DOI Google Scholar
[98]

Y. Ma, X.Y. Li, A.J. Li, et al. H2S-activable MOF nanoparticle photosensitizer for effective photodynamic therapy against cancer with controllable singlet-oxygen release. Angewandte Chemie International Edition, 2017, 56(44): 13752−13756. https://doi.org/10.1002/anie.201708005
DOI Google Scholar
Publication history
Copyright
Rights and permissions

Publication history

Received: 17 February 2024
Revised: 07 March 2024
Accepted: 25 March 2024
Published: 11 May 2024

Copyright

© The Author(s) 2024.

Rights and permissions

This is an open-access article distributed under  the  terms  of  the  Creative  Commons  Attribution  4.0 International  License (CC BY) (http://creativecommons.org/licenses/by/4.0/), which  permits  unrestricted  use,  distribution,  and reproduction in any medium, provided the original author and source are credited.

Return